dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, January 25th--Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Ultrasound Homepage

Ultrasound-based technology may be able to treat cancer Can it replace radiotherapy one day?

Hitachi Healthcare Americas jumps into health IT with VidiStar acquisition Deal will enhance ultrasound service, product portfolio

AIUM Task Force develops curriculum to standardize ultrasound training for OB/GYN residents

Asia-Pacific imaging market to grow at a CAGR of 10 percent through 2021 Technological advancement is one of the main drivers

Federal jury convicts radiologist on fraud and bribery charges Paid kickbacks for patient referrals and billed over $25 million to insurers

Expert makes the case for patient access to radiology reports Patients want a more active role in their care

Sectra announces MR and ultrasound monitoring capabilities for DoseTrack Will no longer be limited to information from ionizing sources

ContextVision unveils VolarView and GOPView XR2Plus Orthopedic package at RSNA Adds enhancements to handheld ultrasounds and orthopedics

Hologic announces partnership with Clarius Mobile Health at RSNA Will integrate its algorithms with handheld ultrasound scanners

Hitachi unveils single broad-based ultrasound probe at RSNA 'Unlike any other in the sector'

Exablate Neuro Model 4000 system is now
treating a record 1,000 patients worldwide

INSIGHTEC's Exablate Neuro hits 1,000 patient mark

por John Fischer , Staff Reporter
Doctors across the globe are now using INSIGHTEC’s Exablate Neuro Model 4000 system to treat more than 1,000 patients for essential tremor and to conduct research, a record number for the MR-guided focused ultrasound treatment.

The treatment is currently administered at 30 medical centers in 10 countries with 80 percent of patients suffering from ET who did not respond to medication prescribed for the condition. The other 20 percent underwent treatment for research purposes.

Story Continues Below Advertisement

Streamline Your Radiology Workflow with RamSoft's PowerServer RIS/PACS

The PowerServer RIS/PACS is a single database application, essential to reducing redundant work, limiting manual data entry, and increasing consistency throughout healthcare practices. Click to learn how it will help you improve patient care and more.



“The standard of care is medication, however, it is estimated that ~40% are refractory to medications … given the immediate reduction patients see in their tremor, the heightened quality of patient care, and the potential reduced costs to the health care system, we hope to see focused ultrasound adopted as the new standard of care for essential tremor,” Maurice Ferre, the CEO and chairman of INSIGHTEC, told HCB News.

The milestone follows the one year anniversary of the FDA’s approval of Exablate Neuro in July 2016 for use with 3.0T MR systems, and indicates an increased interest in the use of focused ultrasound treatments, much of which was generated by regulatory approval in the U.S., Europe, South Korea, Canada, Israel and Japan. The FDA also approved the device in May for use with 1.5 MR systems.

The device differs from other treatments, such as surgery, in that it is noninvasive and reduces risks, such as infection, bleeding and recovery time, and allows patients to quickly resume their lives.

Aside from ET, the technology is also devised to be CE-marked for treating tremors in Parkinson’s disease patient and neuropathic pain. INSIGHTEC is hoping that further research of Exablate Neuro will introduce focused ultrasound as a treatment for other areas of health.

“The company is also working to expand the indications of focused ultrasound in the brain, including neurodegenerative diseases like Parkinson’s disease, epilepsy, OCD, and depression,” said Ferre. “In parallel, we are in the early development of focused ultrasound technology that can disrupt the blood-brain barrier. This development is monumental, as it holds the potential to deliver targeted drug therapies for various brain diseases.”

INSIGHTEC hopes to increase the number of facilities that Exablate Neuro is used in so that fewer people will have to travel for treatment, and hopes to expand coverage to reduce the burden of cost.

“As the benefits of the treatment become more well known, we expect more hospitals to invest in the technology,” said Ferre. “Our other primary objective is to have this treatment covered by CMS and private health care payers. Many patients are paying for this procedure out-of-pocket, so it’s imperative for the treatment to be accessible to all essential tremor patients. Essential tremor impacts people of all ages who want to maintain an active lifestyle.”

Ultrasound Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS